 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Woiwode Thomas
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-07-25 Purchase | 2016-07-25 5:09 pm | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 35,000 | $15 | $525,000 | 11,308 (Indirect) | View |
| 2016-10-18 Purchase | 2016-12-23 6:03 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 161,000 | $14 | $2,254,000 | 185,987 (Indirect) | View |
| 2017-11-24 Sale | 2017-11-28 4:11 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 1,900 | $20.21 | $38,406 | 8,018 (Direct) | View |
| 2017-12-22 Sale | 2017-12-27 4:14 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 3,059 | $20.29 | $62,070 | 4,959 (Direct) | View |
| 2018-04-20 Sale | 2018-04-24 7:42 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 101,994 | $50.68 | $5,168,901 | 117,173 (Indirect Direct) | View |
| 2018-04-24 Sale | 2018-04-26 5:01 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 22,841 | $50.99 | $1,164,655 | 115,645 (Indirect) | View |
| 2018-04-26 Sale | 2018-04-30 8:57 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 222,258 | $50.11 | $11,136,437 | 100,780 (Indirect) | View |
| 2018-04-30 Sale | 2018-05-02 6:00 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 30,566 | $50.29 | $1,537,138 | 98,736 (Indirect Direct) | View |
| 2018-05-07 Sale | 2018-05-09 5:15 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 121,362 | $50.39 | $6,115,873 | 5,629 (Indirect Direct) | View |
| 2018-05-15 Sale | 2018-05-17 5:11 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 44,000 | $57.99 | $2,551,440 | 640,014 (Indirect Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:57 pm | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 225,000 | $18 | $4,050,000 | 933,352 (Indirect) | View |
| 2020-03-03 Purchase | 2020-03-03 7:03 pm | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 225,000 | $18 | $4,050,000 | 933,352 (Indirect Direct) | View |
| 2020-10-20 Purchase | 2020-10-20 5:00 pm | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 200,000 | $15 | $3,000,000 | 862,444 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-05-11 Option Award | 2016-07-01 6:18 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 24,155 | $0 | 44,248 (Direct) | View |
| 2016-05-11 Option Award | 2016-07-01 6:18 pm | N/A 2026-05-10 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 44,248 | $4.14 | 44,248 (Direct) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 1,081,477 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 480,856 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 198,410 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 6,811 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 3,029 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 1,249 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 1,081,477 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 480,856 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 198,410 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 6,811 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 3,029 | $0 | 11,308 (Indirect) | View |
| 2016-07-25 Conversion | 2016-07-25 5:09 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 1,249 | $0 | 11,308 (Indirect) | View |
| 2016-08-24 Option Award | 2016-08-25 9:55 pm | N/A 2026-08-24 | Audentes Therapeutics Inc. | BOLD | Woiwode Thomas Director | 18,000 | $15.03 | 18,000 (Direct) | View |
| 2016-10-18 Option Award | 2016-10-20 5:14 pm | N/A 2026-10-18 | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 30,000 | $14 | 30,000 (Direct) | View |
| 2016-10-31 Option Award | 2016-11-01 6:48 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 3,390 | $0 | 27,545 (Direct) | View |
| 2016-11-30 Option Award | 2016-12-01 6:05 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 3,509 | $0 | 31,054 (Direct) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 437,247 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 3,100,477 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 231,077 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 2,754 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 19,524 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 1,454 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 2,210,417 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 173,167 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 66,490 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 5,210 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 168,224 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 13,180 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 73,704 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 5,774 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Option Award | 2016-12-23 6:03 pm | N/A 2026-10-18 | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 30,000 | $14 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 437,247 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 2,754 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 3,100,477 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 19,524 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 2,210,417 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 66,490 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 168,224 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 73,704 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 231,077 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 1,454 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 173,167 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 5,210 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 13,180 | $0 | 185,987 (Indirect) | View |
| 2016-10-18 Conversion | 2016-12-23 6:03 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 5,774 | $0 | 185,987 (Indirect) | View |
| 2016-12-30 Option Award | 2017-01-03 5:27 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 3,449 | $0 | 34,503 (Direct) | View |
| 2017-01-31 Option Award | 2017-02-02 4:41 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 3,449 | $0 | 37,952 (Direct) | View |
| 2017-02-28 Option Award | 2017-03-02 4:58 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 3,774 | $0 | 41,726 (Direct) | View |
| 2017-03-31 Option Award | 2017-04-03 5:57 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 3,704 | $0 | 45,430 (Direct) | View |
| 2017-04-28 Option Award | 2017-05-01 8:20 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 2,223 | $0 | 47,653 (Direct) | View |
| 2017-05-31 Option Award | 2017-06-02 4:30 pm | N/A 2027-05-31 | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 30,000 | $13.62 | 30,000 (Indirect) | View |
| 2017-06-12 Option Award | 2017-06-14 7:11 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 22,727 | $0 | 33,602 (Direct) | View |
| 2017-06-12 Option Award | 2017-06-14 7:11 pm | 2018-06-12 2027-06-11 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 33,602 | $2.75 | 33,602 (Direct) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 1,368,013 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 8,110 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 814,599 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 23,899 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 61,993 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 26,491 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 292,529 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 292,529 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 17,283 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 17,283 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 1,240 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 1,240 | $0 | 9,918 (Indirect) | View |
| 2017-09-05 Other | 2017-09-07 9:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 9,918 | $0 | 9,918 (Direct) | View |
| 2018-04-20 Other | 2018-04-24 7:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 497,053 | $0 | 117,173 (Indirect) | View |
| 2018-04-20 Other | 2018-04-24 7:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 2,947 | $0 | 117,173 (Indirect) | View |
| 2018-04-20 Other | 2018-04-24 7:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 92,918 | $0 | 117,173 (Indirect) | View |
| 2018-04-20 Other | 2018-04-24 7:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 92,918 | $0 | 117,173 (Indirect) | View |
| 2018-04-20 Other | 2018-04-24 7:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 2,323 | $0 | 117,173 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-15 4:27 pm | N/A 2028-05-30 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 35,000 | $6.25 | 35,000 (Direct) | View |
| 2018-06-15 Option Award | 2018-06-15 9:39 pm | N/A 2028-06-15 | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 30,000 | $59.31 | 30,000 (Indirect) | View |
| 2018-10-02 Conversion | 2018-10-02 5:29 pm | N/A N/A | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 3,102,929 | $0 | 0 (Indirect) | View |
| 2018-10-02 Conversion | 2018-10-02 5:29 pm | N/A N/A | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 2,173,909 | $0 | 0 (Indirect) | View |
| 2018-10-02 Conversion | 2018-10-02 5:29 pm | N/A N/A | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 929,020 | $0 | 0 (Indirect) | View |
| 2019-06-19 Option Award | 2019-06-20 4:17 pm | N/A 2029-06-19 | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 8,570 | $10.86 | 8,570 (Direct) | View |
| 2019-07-31 Option Award | 2019-08-02 4:25 pm | N/A 2029-07-30 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 45,000 | $13.41 | 45,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 6:01 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 33,836 | $18 | 33,836 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 2,977,242 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 1,049,175 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 708,352 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 2,977,242 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 1,049,175 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 708,352 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2,977,242 | $0 | 933,352 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 1,049,175 | $0 | 933,352 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 708,352 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2,977,242 | $0 | 933,352 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 1,049,175 | $0 | 933,352 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 708,352 | $0 | 933,352 (Indirect) | View |
| 2020-06-18 Option Award | 2020-06-22 5:40 pm | N/A 2030-06-18 | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 12,500 | $6.66 | 12,500 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 5:45 pm | N/A 2030-06-22 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 30,000 | $25.64 | 30,000 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 2,145,991 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 198,839 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 85,065 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 463,959 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 198,485 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 2,145,991 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 198,839 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 463,959 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 85,065 | $0 | 862,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 198,485 | $0 | 862,444 (Indirect) | View |